Form 4 for CRMD CorMedix Inc.
Accepted 2026-09-18 21:36:46 ET · period of report 2026-09-18 · accession 0001213900-26-101594 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-18 21:36 | 2026-09-18 | CRMD | Dillione Janet | Dir | M - OptEx | — | +48.9K | 117.8K | +71% | — |
| D | 2026-09-18 21:36 | 2026-09-18 | CRMD | Dillione Janet | Dir | M - OptEx | — | -48.9K | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-18 | M | A | 48,909 | — | 117,835 | D | — | — | (F1) Each phantom stock unit is the economic equivalent of one share of common stock. On September 17, 2025, the Company terminated the CorMedix Inc. Deferred Compensation Plan for Directors (the "Plan"). On September 18, 2026, in connection with the termination of the Plan, all of the Reporting Person's phantom stock units were settled in an equal number of shares of common stock. |
| 2 | Derivative | Phantom Stock | 2026-09-18 | M | D | 48,909 | — | 0 | D | — · — to — | 48,909 Common Stock | (F1) Each phantom stock unit is the economic equivalent of one share of common stock. On September 17, 2025, the Company terminated the CorMedix Inc. Deferred Compensation Plan for Directors (the "Plan"). On September 18, 2026, in connection with the termination of the Plan, all of the Reporting Person's phantom stock units were settled in an equal number of shares of common stock. (F1) Each phantom stock unit is the economic equivalent of one share of common stock. On September 17, 2025, the Company terminated the CorMedix Inc. Deferred Compensation Plan for Directors (the "Plan"). On September 18, 2026, in connection with the termination of the Plan, all of the Reporting Person's phantom stock units were settled in an equal number of shares of common stock. (F1) Each phantom stock unit is the economic equivalent of one share of common stock. On September 17, 2025, the Company terminated the CorMedix Inc. Deferred Compensation Plan for Directors (the "Plan"). On September 18, 2026, in connection with the termination of the Plan, all of the Reporting Person's phantom stock units were settled in an equal number of shares of common stock. (F1) Each phantom stock unit is the economic equivalent of one share of common stock. On September 17, 2025, the Company terminated the CorMedix Inc. Deferred Compensation Plan for Directors (the "Plan"). On September 18, 2026, in connection with the termination of the Plan, all of the Reporting Person's phantom stock units were settled in an equal number of shares of common stock. |